Silver Book Fact

Hospitalization from incorrect diagnosis of heart attacks costs $12 billion per year. If creatine kinase, myoglobin and troponin are used for detecting heart attack in ER patients with chest pain, costs can be reduced by approximately 30%.

Maisel, Alan, Kathleen Templin, and Martha Love, Paul Clopton. A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran’s Hospital. Clinical Cardiology. 2000; 23: 915-920

Reference

Title
A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran’s Hospital
Publication
Clinical Cardiology
Publication Date
2000
Authors
Maisel, Alan, Kathleen Templin, and Martha Love, Paul Clopton
Pages
915-920

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • Compared to standard coverage, 3 years of full coverage for prevention medications will reduce mortality and reinfarction rates and will save $5,974 per patient.  
  • Every additional dollar spent on antiplatelet therapy versus aspirin for the prevention of stroke in high-risk patients, has produced health gains valued between $2 and $6.  
  • Full medication coverage is expected to increase patient compliance from 50% to 76%. Expanded coverage would cost insurers an average of $644 more per patient, but would avert an average…